Literature DB >> 14680667

Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction.

Holger J Schünemann1, Lauren Griffith, Roman Jaeschke, Roger Goldstein, David Stubbing, Gordon H Guyatt.   

Abstract

BACKGROUND/
OBJECTIVES: The chronic respiratory questionnaire (CRQ), the St. Georges Respiratory Questionnaire (SGRQ), and the feeling thermometer (FT) evaluate change in health-related quality of life (HRQL) in patients with chronic airflow limitation (CAL). Although the interpretability, and in particular the minimal important difference (MID) in score changes, is well established for the CRQ, this is not the case for the SGRQ and FT. The objective of our study is to explore the interpretation of the SGRQ and FT.
METHODS: We analyzed data from 84 patients who completed the CRQ, SGRQ, and FT before beginning pulmonary rehabilitation and 3 months later. We calculated correlations between the four CRQ domains (dyspnea, fatigue, emotional function, and mastery) and the three SGRQ domains (symptoms, activities, and impact), the SGRQ total score, and the FT. When Pearson's correlations were >/=0.5, we constructed regression equations and used the slope to calculate the change in SGRQ and FT score that corresponded to a change in CRQ score of 0.5 (the MID). Having established MID for SGRQ we than used a similar approach to examine the relation between the SGRQ and FT results.
RESULTS: Comparison with the CRQ dyspnea domain suggested the MID in SGRQ total score is approximately 3.05 with a 95% confidence interval (95% CI) ranging from 0.39 to 5.71 and a change of 5.67 (95% CI 3.43-7.92) represents a moderate change (1.0 on the CRQ dyspnea domain). The MID for the FT based on the CRQ fatigue domain was 6.1 (95% CI 1.87-10.28). The FT MID based on the SGRQ activities domain, impacts domain, and total score were, respectively, 7.4 (95% CI 3.44-11.35), 5.6 (95% CI 1.6-9.64), and 5.9 (95% CI 1.97-9.78).
CONCLUSIONS: An MID for the SGRQ approximates the previously suggested estimate of 4 on a scale of 0 to 100. The MID for the FT in patients with CAL is approximately 5 to 8 units on the 0 to 100 scale. These MID estimates should facilitate interpretation of clinical trials in which outcome measures include the SGRQ or FT.

Entities:  

Mesh:

Year:  2003        PMID: 14680667     DOI: 10.1016/s0895-4356(03)00115-x

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  53 in total

Review 1.  How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction.

Authors:  M A Puhan; H J Schünemann; M Frey; M Scharplatz; L M Bachmann
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

2.  Do clinical marker states improve responsiveness and construct validity of the standard gamble and feeling thermometer: a randomized multi-center trial in patients with chronic respiratory disease.

Authors:  Holger J Schünemann; Roger Goldstein; M Jeffery Mador; Douglas McKim; Elisabeth Stahl; Lauren E Griffith; Ahmed M Bayoumi; Peggy Austin; Gordon H Guyatt
Journal:  Qual Life Res       Date:  2006-02       Impact factor: 4.147

3.  Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials.

Authors:  Manisha Jhamb; Manjula K Tamura; Jennifer Gassman; Amit X Garg; Robert M Lindsay; Rita S Suri; George Ting; Fredric O Finkelstein; Scott Beach; Paul L Kimmel; Mark Unruh
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

4.  Efficacy of a simple and inexpensive exercise training program for advanced chronic obstructive pulmonary disease patients in community hospitals.

Authors:  Chaicharn Pothirat; Warawut Chaiwong; Nittaya Phetsuk
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

5.  The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.

Authors:  Jeffrey J Swigris; Meilan Han; Rekha Vij; Imre Noth; Eric L Eisenstein; Kevin J Anstrom; Kevin K Brown; Diane Fairclough
Journal:  Respir Med       Date:  2012-07-15       Impact factor: 3.415

6.  The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease.

Authors:  Aline Almeida Gulart; Anelise Bauer Munari; Suelen Roberta Klein; Raysa Silva Venâncio; Hellen Fontão Alexandre; Anamaria Fleig Mayer
Journal:  Braz J Phys Ther       Date:  2019-03-26       Impact factor: 3.377

7.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

Authors:  Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman
Journal:  Addiction       Date:  2015-12-17       Impact factor: 6.526

8.  Evaluation of a combined strategy directed towards health-care professionals and patients with chronic obstructive pulmonary disease (COPD): information and health education feedback for improving clinical monitoring and quality-of-life.

Authors:  Carles Valero; Mònica Monteagudo; Maria Llagostera; Xavier Bayona; Sílvia Granollers; Mateo Acedo; Juan J Ferro; Lluïsa Rodríguez-Latre; Jesús Almeda; Laura Muñoz
Journal:  BMC Public Health       Date:  2009-12-01       Impact factor: 3.295

Review 9.  Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations.

Authors:  Thomas Glaab; Claus Vogelmeier; Roland Buhl
Journal:  Respir Res       Date:  2010-06-17

10.  Effect of a noninvasive ventilatory support during exercise of a program in pulmonary rehabilitation in patients with COPD.

Authors:  Shahin Barakat; Germain Michele; Pascale Nesme; Viallet Nicole; Annat Guy
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.